MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11136-026-04227-7

Медицинская библиотека · Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026

Development of the novel nontuberculous mycobacterial pulmonary disease symptoms scale (NTM-SS).

Henkle E, Dieckmann N F, Franklin H, Cella D, Megson G, Daley C L, Flume P A, McShane P J, Winthrop K L, Quittner A L

СтатьяПеревод в очереди

Аннотация

AIMS: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic infection often necessitating long-term, multidrug treatment. Here we report the development of a novel disease-specific patient-reported outcome measure (PROM) for use as a clinical trial endpoint.

METHODS

We performed a literature review and conducted semi-structured interviews with adult subjects with NTM-PD recruited from four U.S. clinical sites. Interviews were recorded, transcribed, and consensus coded. NTM Symptom Scale (NTM-SS) items were selected and tested in cognitive interviews. We refined the NTM-SS using theoretical relevance/face validity, exploratory factor analysis (factorial validity), item response theory (IRT) and traditional reliability estimation, and convergent validity testing.

RESULTS

The concept elicitation interviews identified key symptoms of cough (100%), shortness of breath (98%), fatigue (95%), sputum production (90%), throat clearing (80%), mental fogging (75%), sensitivity to cold (62%), night sweats (55%), poor appetite (53%), chills/feverishness (50%/43%), weight loss (48%), and chest congestion (45%). Within the conceptual framework of Respiratory Symptoms, Fatigue, and other NTM Symptoms, we selected an initial set of 44 items, editing 4 items after cognitive testing. Psychometric testing resulted in 7 subscales (final: 32 items). Scale reliabilities ranged from 0.85 to 0.95. Test–retest reliability was high (r = 0.73–0.88), and subscales showed strong convergent validity with existing measures (r = 0.64–0.87).

CONCLUSION

We identified a 32-item disease-specific PROM with a highly reliable set of 7 subscales. Separately scored NTM-SS subscales allow for selection of appropriate clinical trial endpoints. Further validation, including responsiveness to change, is needed.

Для цитирования: Henkle E, Dieckmann N F, Franklin H, Cella D, Megson G, Daley C L, Flume P A, McShane P J, Winthrop K L, Quittner A L. Development of the novel nontuberculous mycobacterial pulmonary disease symptoms scale (NTM-SS).. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2026. DOI: 10.1007/s11136-026-04227-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.